Long-Term Treatment with Extended-Release Carbidopa–Levodopa (IPX066) in Early and Advanced Parkinson’s Disease: A 9-Month Open-Label Extension Trial

被引：0
|
作者：
Cheryl H. Waters
Paul Nausieda
Lyudmila Dzyak
Joerg Spiegel
Monika Rudzinska
Dee E. Silver
Elena S. Tsurkalenko
Sherron Kell
Ann Hsu
Sarita Khanna
Suneel Gupta
机构：
[1] Columbia University Medical Center,
[2] Wisconsin Institute for Neurologic and Sleep Disorders,undefined
[3] Dnipropetrovsk State Medical Academy,undefined
[4] Saarland University,undefined
[5] Medical University of Silesia,undefined
[6] Coastal Neurological Medical Group,undefined
[7] Impax Laboratories,undefined
[8] Inc.,undefined
[9] Columbia University,undefined
来源：
CNS Drugs | 2015年 / 29卷
关键词：
Levodopa; Rasagiline; Carbidopa; Patient Global Impression; Maximum Plasma Drug Concentration;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：341 / 350
页数：9
相关论文
共 50 条
  • [1] Long-Term Treatment with Extended-Release Carbidopa-Levodopa (IPX066) in Early and Advanced Parkinson's Disease: A 9-Month Open-Label Extension Trial
    Waters, Cheryl H.
    Nausieda, Paul
    Dzyak, Lyudmila
    Spiegel, Joerg
    Rudzinska, Monika
    Silver, Dee E.
    Tsurkalenko, Elena S.
    Kell, Sherron
    Hsu, Ann
    Khanna, Sarita
    Gupta, Suneel
    CNS DRUGS, 2015, 29 (04) : 341 - 350
  • [2] Randomized trial of IPX066, carbidopa/levodopa extended release, in early Parkinson's disease
    Pahwa, Rajesh
    Lyons, Kelly E.
    Hauser, Robert A.
    Fahn, Stanley
    Jankovic, Joseph
    Pourcher, Emmanuelle
    Hsu, Ann
    O'Connell, Martin
    Kell, Sherron
    Gupta, Suneel
    PARKINSONISM & RELATED DISORDERS, 2014, 20 (02) : 142 - 148
  • [3] Long-Term Safety of IPX066 Extended-Release Carbidopa-Levodopa Capsules in Patients with Early Parkinson's Disease
    Nausieda, Paul
    Rudzinska, Monika
    Kell, Sherron
    O'Connell, Martin
    Hsu, Ann
    Gupta, Suneel
    NEUROLOGY, 2013, 80
  • [4] Efficacy of carbidopa-levodopa extended-release capsules (IPX066) in the treatment of Parkinson Disease
    Mueller, Thomas
    Moehr, Jan-Dominique
    EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (18) : 2063 - 2071
  • [5] Long-Term Safety of IPX066 Extended-Release Carbidopa-Levodopa Capsules in Patients with Motor Fluctuations in Advanced Parkinson's Disease
    Ellenbogen, Aaron
    Nausieda, Paul
    Pourcher, Emmanuelle
    Rudzinska, Monika
    Kell, Sherron
    O'Connell, Martin
    Hsu, Ann
    Gupta, Suneel
    NEUROLOGY, 2013, 80
  • [6] Efficacy and Safety of IPX066, a Carbidopa-Levodopa, Extended-Release Formulation, in Early Parkinson's Disease
    Pahwa, Rajesh
    Elllenbogen, Aaron
    Kell, Sherron
    O'Conell, Martin
    Hauser, Robert
    Fahn, Stanley
    Jankovic, Joseph
    Pourcher, Emmanuelle
    Hsu, Ann
    Gupta, Suneel
    ANNALS OF NEUROLOGY, 2013, 74 : S47 - S47
  • [7] Efficacy of IPX066, extended-release levodopa-carbidopa in patients with advanced Parkinson's disease: Responder analyses
    Gupta, Suneel
    Khanna, Sarita
    Rustay, Nathan
    Rubens, Robert
    Kell, Sherron
    MOVEMENT DISORDERS, 2017, 32 : S36 - S36
  • [8] Conversion to IPX066, extended-release carbidopa-levodopa, in advanced Parkinson's disease patients: Dosing patterns
    Morgan, J.
    Stacy, M.
    Rubens, R.
    Khanna, S.
    Gupta, S.
    MOVEMENT DISORDERS, 2016, 31 : S659 - S659
  • [9] Efficacy of IPX066, an extended-release formulation of carbidopa-levodopa, in advanced Parkinson's disease patients with troublesome dyskinesia
    Dhall, R.
    Struck, L.
    Rubens, R.
    Shah, V.
    Gupta, S.
    MOVEMENT DISORDERS, 2015, 30 : S79 - S80
  • [10] Safety of IPX066, an extended release carbidopa-levodopa formulation, for the treatment of Parkinson's disease
    Kestenbaum, Meir
    Fahn, Stanley
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (05) : 761 - 767
12345